Q. In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

View solution

Q. In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

View solution

Q. In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

View solution

Q. In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

View solution

Q. In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

View solution

Q. Which model is also known as membrane permeation rate limited?

View solution

Q. Which of the following will be a disadvantage for the physiologic model?

View solution

Q. Which pharmacokinetic model is drawn on the basis of anatomic and physiologic data?

View solution

Q. In noncompartmental analysis, Mean residence time is equal to _____________

View solution

Q. Which of the following is not a characteristic of the caternary compartment model?

View solution

Q. In which model compartments are joined in series?

View solution

Q. Which organs will make up the peripheral compartment?

View solution

Q. In which of the model peripheral compartments are connected to a central compartment?

View solution

Q. In which of the following models the body is considered to be composed of several compartments?

View solution

Q. Which of the following is not a mechanism for pharmacokinetic analysis?

View solution

Q. The time period for which the plasma concentration of drug remains above minimum effective concentration is known as ______________

View solution

Q. Haemodialysis is also known as extracorporeal dialysis.

View solution

Q. Which of the following will not be a factor governing the removal of substances through dialysis?

View solution

Q. Which kind of membrane is used in haemodialysis?

View solution

Q. Drugs in patients with renal impairment have same pharmacokinetic profile as in a person without renal failure.

View solution